Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In an ovarian cancer case study, Dr. Feldman uses this instrumentation to modernize pathology.
PerkinElmer is serving in a central role in two EU-based consortia based projects focused on tracing the fate of nanomaterials to determine their potential toxicity and impact on air, soil, and water.
PerkinElmer scientists in concert with colleagues from the University Hospital of Wales and Cardiff University have developed a new immunoassay screen for Duchenne Muscular Dystrophy.
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a colorectal case study, Dr. Galon uses this instrumentation to uncover more details about cancer and the immune system.
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a breast cancer case study, Dr. Rimm uses this instrumentation in her immune-oncology research.
Two years after forming a strategic collaboration AMRI and PerkinElmer are helping to eliminate research and clinical data silos and advance precision medicine.
An overview of India's ambitious National Optical Fiber Network and the roles Jain Irrigation Systems, Ltd., and PerkinElmer are playing as one of the world’s largest fiber optic networks become a reality.
Research at Institut Pasteur de Lille using PerkinElmer’s Opera® High-Content Screening System and Acapella® Image Analysis Software contributes substantial new information to our understanding of M. tuberculosis.
For over 40 years PerkinElmer has been the official instrument supplier and fuel certification sponsor for the INDYCAR® Series.
Cancer researchers now can visualize more of a tumor than ever before using PerkinElmer’s Phenoptics Quantitative Pathology Research Solutions. In a melanoma case study, Dr. Tumeh uses this instrumentation to develop biomarkers in his cancer immunology research.